EON

New Study Offers Evidence These Mushrooms May Benefit Patients

Baltimore, MD-It is decades past the hype era of LSD and magic mushrooms, but the possible medical usage of psychedelic drugs continues to be the subject of research for some scientists in the field.

Researchers at Johns Hopkins Medical Center in Baltimore reported in the year 2006 that they were experimenting with psilocybin, which is the chemical found in hallucinogenic mushrooms.

They tested the results of small amounts of psilocybin on 36 different volunteers who were administered the drug in a laboratory setting.

After two years, the subjects are reporting that the spiritual and hallucination effects that they experienced while testing the psilocybin drug continues for many of the patients who took the drug.

“Most of the patient volunteers that took the drug looked back after 14 months and said that experimenting as a volunteer was one of the top 5 meaningful experiences in their lives,” said Roland Griffiths.

Roland Griffiths is the lead Johns Hopkins researcher and author of the study report.

The scientists believe that in carefully controlled amounts the psilocybin drug may have potential in treating people with depression or anxiety, or other serious illness.

They also believe it may have a future to help treat other drug dependency.